Editorial Series
Search for
Sort by 
Page
Showing 1 - 14 of 14 documents.
Editorial series
Oct 30, 2009 12:35 EDT
How do regulatory pathways differ in the US and UK? Drs Harrington, Bhatt, and Cleland share their experiences and offer insight on how to support innovative research.
Editorial series
Oct 23, 2009 10:40 EDT
Dr Melissa Walton-Shirley talks to Dr Nassir Marrouche about the results of RE-LY, the impact of dronedarone on the treatment of atrial fibrillation, and his hopes for the future of MRI-guided ablation.
Editorial series
Oct 16, 2009 10:00 EDT
Join heartwire's Lisa Nainggolan as she talks to Drs Franz Messerli and Melissa Walton-Shirley about the results of the KYOTO HEART Study, what they mean for North American and European populations, and the future role of angiotensin-receptor blockers (ARBs).
Editorial series
Oct 2, 2009 13:45 EDT
Join 'heartwire's Steve Stiles as he talks to Drs Nassir Marrouche and Clyde Yancy about MADIT-CRT, the potential benefits and costs for the heart-failure population in light of the trial, and about why the Europeans seem to be ahead of the guidelines in the European CRT Survey.
Editorial series
Sep 15, 2009 14:10 EDT
Dr Robert Califf sits down with Drs Alfred Bove, Jack Lewin, and Clyde Yancy and AHA CEO Nancy Brown to talk about the ACC and the AHA and their role in the debate on healthcare reform.
The Cardiology Show
Sep 2, 2009 11:15 EDT
Dr Valentin Fuster returns to the city where he was born for a scintillating discussion with Drs Fox, Gershlick, Marrouche, Messerli, Spaulding, Vergheugt, Virmani, and Yancy about the miracle of RE-LY and the striking success of ticagrelor in the PLATO study.
Editorial series
May 12, 2009 15:15 EDT
Drs Melissa Walton-Shirley and Clyde Yancy review the latest data on heart failure from ACC 2009, including STICH, Pre-RELAX-AHF, PRIMA, and more.
The Cardiology Show
Apr 2, 2009 15:35 EDT
Join Drs Valentin Fuster, Anne Curtis, Timothy Gardner, Barry Greenberg, Cindy Grines, Bob Harrington, Sanjay Kaul, Harlan Krumholz, and Salim Yusuf as they unravel the STICH trial and debate the lessons learned from PROTECT-AF in Part 1 of the Cardiology Show. In Part 2 of the program, the JUPITER trial is back on the table and our experts give their opinion on the polypill following the results of the TIPS study.
Editorial series
Mar 9, 2009 08:00 EDT
What role is there for new biomarkers in the biological management of heart failure? Join Dr James Januzzi as he discusses the role of ST2 in this rapidly expanding field and how ST2 can help to improve the care of patients with heart failure.
Editorial series
1 COMMENT - Feb 13, 2009 13:53 EST
What is the role of a structured exercise program for your patients with NYHA class 2/3 heart failure? Join Dr Ileana Piņa's presentation of the results of HF-ACTION, presented at AHA, and the implications of the findings for patient care.
HeartWire clips
Dec 16, 2008 13:00 EST
Join theheart.org's forum moderator in these in-depth interviews filmed on location at major congresses
Ten years in review
1 COMMENT - Dec 3, 2008 14:30 EST
As theheart.org enters its 10th year join editor-in-chief, Dr Eric Topol, and his guests for a second look at the top news from the past decade. Throughout the coming months, we'll revisit the most important story from each of the last 10 years and ask: How has practice been affected? With time and perspective, what has changed and what have we learned?
Cardiology panels
Jul 15, 2008 16:33 EDT
Join Dr Melissa Walton-Shirley as she talks to Drs Ileana Piņa, Clyde Yancy, and cardiology fellow Eiran Gorodeski about the current state of treatment for decompensated congestive heart failure, why we need to remember the fundamentals, and some exciting data from the PROTECT-1 pilot study.
Cardiology panels
18 COMMENTS - Dec 17, 2007 12:00 EST
Join Dr Melissa Walton-Shirley as she talks to Drs Clyde Yancy and Roger Blumenthal about CORONA, RETHINQ, MASTER-1, and the AF/CHF trial and why sticking with the basics might be the best approach for congestive heart failure.

Search for
Sort by 
Page
Showing 1 - 14 of 14 documents.
button
Previews
Featured programs
Poll
How important a consideration is patient age alone in deciding whether to recommend implantation of a primary-prevention defibrillator to a 90-year-old man with heart failure and an LVEF of 35% but no significant comorbidities?
See: More questions about primary-prevention ICD benefit in the very old with comorbidities
Very important
Moderately important
Not very important

Inside: Heart failure